Factors associated with obstetric cholestasis in a tertiary hospital in Nepal: A case control study

Authors

  • Dr. Sweta Department of Obstetrics and Gynaecology, Dhulikhel Hospital, Nepal
  • Tulika Department of Emergency Medicine, Grande City Hospital, Nepal
  • Dr. Sanjeev Department of Obstetrics and Gynaecology, Scheer Memorial Adventist Hospital, Nepal
  • Dr. Anamika Department of Paediatrics, Dhulikhel Hospital, Nepal
  • Adarsh Department of Orthopaedics, Armed Police Hospital, Nepal
  • Resham Gautam Department of Internal Medicine, Lumbini Medical college, Nepal
  • Sajana Nursing Instructor, Tulsipur City Hospital, Nepal

DOI:

https://doi.org/10.62992/7njv2z52

Keywords:

Fetal complications, Maternal complications, Obstetric cholestasis

Abstract

Background: Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disorder in pregnancy and is associated with an increased risk of adverse obstetrical outcomes like sudden fetal demise. It frequently develops in third trimester in pregnancy. It commonly occurs in individuals who are genetically predisposed.  It is characterized by generalized itching, with no other skin manifestations.  Maternal outcomes for patients diagnosed with ICP mild however, fetal outcomes are serious. 

Objectives: To evaluate pregnancy outcomes and fetal complications associated with women with Obstetric cholestasis.

Methods: A retrospective case control study was conducted among women with Obstetric Cholestasis in Dhulikhel hospital in Nepal from April 2022 to April 2023. All the patients in the obstetrics and gynaecology labour room (Dhulikhel Hospital) with the diagnosis of Obstetric cholestasis in a given time frame were included. Secondary research data such as existing medical records and database were used for this study. Odds Ratio and its 95% CI was calculated by using unconditional logistic regression. P-value of <0.05 was considered as significant.

Results: The incidence of ICP was 4.2%. Majority of women with obstetric cholestasis belonged to age group 26-30 years. Majority of them were primigravida. This study identified that maternal and fetal complications were higher in women with obstetric cholestasis. The complications like Primary Postpartum Haemorrhage (PPH) (OR=2.43, 95%CI:1.03-5.76, p 0.042), meconium stained liquor (OR=4.44, 95%CI:2.26-8.72, p <0.001), abnormal Cardiotocography (CTG) (OR= 3.88, 95%CI: 1.83-8.23, p <0.001), Intrauterine Growth Retardation(IUGR) (OR=6.73, 95%CI: 3.06-14.78, p <0.001), Neonatal Intensive Care Unit (NICU)  admission (OR=3.49, 95%CI: 1.61-7.61, p 0.002), low APGAR score  (OR=2.31, 95%CI: 1.09-4.92, p 0.029) and neonatal Death (OR=3.16, 95%CI: 1.083-9.22, p 0.035) were associated with pregnancies complicated with obstetric cholestasis.

Conclusion: The women with obstetric cholestasis were found to have adverse pregnancy outcome compared to pregnant women without obstetric cholestasis. However, perinatal outcome is good in actively managed women.

References

Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetric cholestasis. British medical journal. 1976;1(6014):870-2.

Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. British journal of obstetrics and gynaecology. 1988;95(11):1137-43.

Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethnicity & health. 1999;4(1-2):35-7.

Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. Journal of gastroenterology and hepatology. 1997;12(3):211-6.

Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstetrics and gynecology. 1999;94(2):189-93.

Holzbach RT, Sivak DA, Braun WE. Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology. 1983;85(1):175-9.

Hirvioja M-L, Kivinen S. Inheritance of intrahepatic cholestasis of pregnancy in one kindred. 1993;43(6):315-7.

Pokhrel Ghimire S, Ghimire A, Jha GS, Chhetry M, Kumar M. Feto-Maternal outcomes in Intrahepatic Cholestasis in Pregnancy in a Tertiary Care Centre in Eastern Nepal. Journal of Nobel Medical College. 2016;5(1):20-5.

Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. American journal of obstetrics and gynecology. 1994;170(3):890-5.

Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology (Baltimore, Md). 1997;26(2):358-64.

Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. American journal of obstetrics and gynecology. 1996;175(4 Pt 1):957-60.

Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 1984;22(2):91-4.

Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology. 2000;118(2):422-30.

Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology. 1997;113(1):255-64.

Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. Journal of hepatology. 2000;33(6):1012-21.

Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology (Baltimore, Md). 1982;2(1):87-96.

Ray Alokananda TRJ, Balsara Roshan, Singhal Sangeeta,. Cholestasis of pregnancy. The Journal of Obstetrics and Gynecology of India. 2005;55(3):247-50.

Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A. Obstetric cholestasis: outcome with active management. European journal of obstetrics, gynecology, and reproductive biology. 2002;100(2):167-70.

Germain AM, Carvajal JA, Glasinovic JC, Kato CS, Williamson C. Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder. Journal of the Society for Gynecologic Investigation. 2002;9(1):10-4.

Padmaja M, Bhaskar P, Kumar GJ, Seetha R, Mahasweta C. A study of obstetric cholestasis: J Obstet Gynaecol India. 2010 Jun;60(3):225-31. doi: 10.1007/s13224-010-0030-3. Epub 2010 Sep 9.

Williamson C, Hems LM, Goulis DG, Walker I, Chambers J, Donaldson O, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG : an international journal of obstetrics and gynaecology. 2004;111(7):676-81.

Rasheed S AS, Mazhar SB. Fetomaternal outcome in patients with obstetric cholestasis. Ann Pak Inst Med Sci. 2019;4(5):211-5.

Downloads

Published

07-06-2024

Issue

Section

Original Article

Categories

How to Cite

1.
Factors associated with obstetric cholestasis in a tertiary hospital in Nepal: A case control study. IJPHAP [Internet]. 2024 Jun. 7 [cited 2024 Jun. 20];3(5):63-70. Available from: https://ijphap.com/index.php/home/article/view/72